Back
Micron Technology 10K Form
Sell
39
MU
Micron Technology
Last Price:
61.11
Seasonality Move:
6.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-07-01 | 10Q | MU/Micron Technology Quarterly |
2021-04-01 | 10Q | MU/Micron Technology Quarterly |
2021-01-08 | 10Q | MU/Micron Technology Quarterly |
2020-10-19 | 10K | MU/Micron Technology Annual |
2020-06-29 | 10Q | MU/Micron Technology Quarterly |
2020-03-26 | 10Q | MU/Micron Technology Quarterly |
Receive MU News And Ratings
See the #1 stock for the next 7 days that we like better than MU
MU Financial Statistics
Sales & Book Value
Annual Sales: | $30.76B |
---|---|
Cash Flow: | $-1.51B |
Price / Cash Flow: | 69.11 |
Annual Sales: | $45.20 |
Price / Book: | 1.29 |
Profitability
EPS (TTM): | 5.51000 |
---|---|
Net Income (TTM): | $6.19B |
Gross Margin: | $13.9B |
Return on Equity: | 12.77% |
Return on Assets: | 9.54% |
Micron Technology Earnings Forecast
Key Micron Technology Financial Ratios
- The Gross Profit Margin over the past 39 years for MU is 45.18%.
- The Selling, General & Administrative Expenses for MU have been equal to 3.47% of Gross Profit Margin.
- The Research & Development expenses have been 10.13% of Revenue.
- The Interest Expense is 2.18% of Operating Income.
- The Net Earning history of MU is 28.24% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 17 years.
Micron Technology Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Semiconductors |
Sector: | Technology |
Current Symbol: | MU |
CUSIP: | 595112 |
Website: | micron.com |
Debt
Debt-to-Equity Ratio: | 0.19 |
---|---|
Current Ratio: | 3.51 |
Quick Ratio: | 2.13 |
Price-to-Earnings
Trailing P/E Ratio: | 7.5 |
---|---|
Forward P/E Ratio: | 43.28 |
MU Technical Analysis vs Fundamental Analysis
Sell
39
Micron Technology (MU)
is a Sell
Is Micron Technology a Buy or a Sell?
-
Micron Technology stock is rated a Sell
The current Micron Technology [MU] share price is $58.11. The Score for MU is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.